Henry O. Gosebruch - Feb 14, 2024 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Role
President & CEO, Director
Signature
/s/ Joshua Pinto, as Attorney-in-Fact for Henry O. Gosebruch
Stock symbol
NMRA
Transactions as of
Feb 14, 2024
Transactions value $
$0
Form type
4
Date filed
2/16/2024, 04:15 PM
Previous filing
Sep 19, 2023
Next filing
Jun 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NMRA Common Stock Award $0 +80K +20.92% $0.00 462K Feb 14, 2024 Direct F1
holding NMRA Common Stock 15K Feb 14, 2024 See Footnote F2
holding NMRA Common Stock 127K Feb 14, 2024 See Footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NMRA Stock Option (Right to Buy) Award $0 +160K $0.00 160K Feb 14, 2024 Common Stock 160K $18.07 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs vest annually measured from February 14, 2024 (the "Vesting Commencement Date"), such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date.
F2 Shares held by HG4KYC TRUST, of which Reporting Person is trustee.
F3 Shares held by Lu Leng Felicia Chua Descendants 2012 Irrevocable Trust, of which Reporting Person is trustee.
F4 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.